|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Errant Gene Therapeutics, LLC
| | | Phone: | (312) 441-1800 | Fax: | (312) 893-2200 | Year Established: | 2003 | Main Contact: | Patrick Girondi, Co-Founder & CEO | | Other Contacts: | Christopher Ballas, Ph.D., Director, Gene Therapy Jason Feldman, Director of Business Operations Edmond Buccellato, CPA, CFO Sam Salman, President
| | Company Description | Errant is a privately held biopharmaceutical company whose mission is the development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as “orphan diseases.” The company is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many of these diseases. Their therapies are currently being developed for hemoglobinopathies and selected cancers. | |
|
|
|
|
|